CVS - Fidelity Freedom 2065 Fund Q4 2024 Review
2025-03-18 08:00:00 ET
Summary
- The fourth quarter of 2024 was volatile for most asset classes against a backdrop of the U.S. election, surging dollar strength, sticky inflation and rising interest rates in some markets.
- Active asset allocation decisions detracted from the Fund's performance versus the Fidelity Freedom® 2030 Composite Index in Q4, whereas the investment performance of the underlying portfolios contributed.
- Most underlying building-block portfolios across all asset classes outperformed or performed roughly in-line with their respective benchmark for the quarter.
- Active risk relative to the Composite index is at the low end of our historical range. The Fund is overweight equities, with a preference for non-U.S. relative to U.S. equities.
Performance Summary
| Cumulative |
| Annualized |
| 3 |
| 1 |
| 3 |
| 5 |
| 10 Year/ LOF1 |
| Month |
| YTD |
| Year |
| Year |
| Year |
| Fidelity Freedom 2065 Fund Gross Expense Ratio: 0.76%2 |
| -2.38% |
| 14.02% |
| 14.02% |
| 3.95% |
| 9.09% |
| 9.94% |
| S&P 500 Index |
| 2.41% |
| 25.02% |
| 25.02% |
| 8.94% |
| 14.53% |
| 15.27% |
| Fidelity Freedom 2065 Composite Index |
| -1.87% |
| 14.40% |
| 14.40% |
| 3.99% |
| 8.77% |
| 9.58% |
| Morningstar Fund Target-Date 2065+ |
| -1.85% |
| 14.48% |
| 14.48% |
| 4.15% |
| 8.90% |
| -- |
| % Rank in Morningstar Category (1% = Best) |
| -- |
| -- |
| 69% |
| 55% |
| 40% |
| -- |
| # of Funds in Morningstar Category |
| -- |
| -- |
| 193 |
| 147 |
| 43 |
| -- |